Furcation Defects, Periodontal Diseases
Conditions
Brief summary
Teeth with furcation grade II defects will be treated with open flap debridement and regenerative therapy with biphasic calcium phosphate combined with either enamel matrix proteins or a collagen membrane.
Interventions
DEVICEBiphasic calcium phosphate (Straumann Bone Ceramic) + collagen membrane (Straumann Jason Membrane)
Regenerative therapy with biphasic calcium phosphate + collagen membrane.
DRUGBiphasic calcium phosphate (Straumann Bone Ceramic) + enamel matrix proteins (Straumann Emdogain)
Regenerative therapy with biphasic calcium phosphate + enamel matrix proteins.
Sponsors
University of Oslo
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)
Eligibility
Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Subject must be ≥ 20 years * Subject must have periodontal disease as determined by the World Workshop 2017 criteria * Subjects must be undergoing periodontal treatment or follow-up and present 1 or more pair of bilateral mandibular molars affected by furcation involvement grade II with PPD \>4 mm, and the furcation fornix must be below a tangential line from the distal to mesial interproximal crestal bone level * Competent to give consent
Exclusion criteria
The following must not be present at the time of enrolment; * Previous radiotherapy to the jaws, current use of chemotherapy, systemic long-term corticosteroid treatment * Present or past use of bisphosphonate treatment * Pregnant or nursing subjects * Patients classified as \> class 2 according to the ASA (American Society of Anesthesiologists) physical status classification * Previous surgical therapy of included furcation defects * Inability to comprehend and respond to the quality of life questionnaire * Dental restorations or prosthesis involving the furcation area * Root fractures or suspected infractions * Caries lesions in the furcation area * No systemic antibiotic treatment within 3 months prior to intervention
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change of furcation grade level | 12 months after treatment | Proportion of sites demonstrating improvement in furcation grade level as measured with Nabers probe |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Changes in defect morphology assessed by CBCT | 24 months after treatment | Cone beam computed tomography will be acquired at baseline, 2 weeks postoperatively and 24 months postoperatively. This outcome measures quantitative morphologic changes in the furcation defects at 24 months |
| Changes in CAL | 12 months after treatment | Changes in clinical attachment level will be measured with a probe in mm |
| Changes in PPD | 12 months after treatment | Changes in pocket probing depth will be measured with a probe in mm |
| Changes in patient-reported quality of life (QoL) | Preoperatively compared to 24 months after treatment | To assess QoL changes related to mouth and teeth prior to therapy to after therapy by the use of The Oral Impacts on Daily Performance (OIDP) instrument. Each question is assessed by a 5-point scale; (1) never affected, (2) less than once a month, (3) once or twice a month, (4) once or twice a week; and (5) every or nearly every day. The higher number represents more severe impact on quality of life; e.g. worse outcome. Each item will be dichotomised yielding the categories (A) affected; including scale categories (2)-(5), and (B) unaffected, including category (1). |
| Pain following surgery | Daily for 1 week postoperatively | Pain sensation for one week posteoperatively will be recorded on a visual analog scale scale from 0-10. 0 is equivalent to no pain, whereas 10 is the highest pain imagineable. |
| Caries assessment | 12 months | Caries in furcation defect assessed with an explorer will be recorded as (Y/N) |
| Radiographic changes | 12 months after treatment | Standardized intraoral bitewing radiographs will be obtained and compared to baseline radiographs |
Countries
Norway
Outcome results
None listed